Cardinal Health
178 of 416 with a diagram, by size
Q2 FY26 Oct 1 – Dec 31, 2025
Revenue$65.63B
+19% year over year
Gross profit$2.40B
4% margin
Operating profit$0.71B
1% margin
Net profit$0.47B
1% margin
The numbers behind the diagram
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 65.63 | 100% | +19% |
| Pharmaceutical & specialty | 56.11 | 85% | +10% |
| Other revenue | 6.10 | 9% | |
| Other segments | 1.71 | 3% | |
| at-Home solutions | 1.13 | 2% | +35% |
| Nuclear precision health | 0.48 | 1% | +28% |
| OptiFreight logistics | 0.10 | 0% | +32% |
| Cost of revenue | −63.23 | 96% | |
| Gross profit | 2.40 | 4% margin | +0pp |
| SG&A | −1.50 | 3% | +0pp |
| Other | −0.19 | 0% | +0pp |
| Operating profit | 0.71 | 1% margin | +0pp |
| Interest & other costs | −0.08 | ||
| Tax | −0.16 | ||
| Net profit | 0.47 | 1% margin | +0pp |
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 64.01 | 100% | +22% |
| Pharmaceutical & specialty | 59.21 | 92% | +23% |
| GMPD | 3.18 | 5% | +2% |
| All other | 1.64 | 3% | +38% |
| Other and unallocated | −0.02 | 0% | |
| Cost of revenue | −61.69 | 96% | |
| Gross profit | 2.32 | 4% margin | +0pp |
| SG&A | −1.46 | 2% | +0pp |
| Other | −0.19 | 1% | +0pp |
| Operating profit | 0.67 | 1% margin | +0pp |
| Interest & other costs | −0.07 | ||
| Tax | −0.14 | ||
| Net profit | 0.45 | 1% margin | +0pp |
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 60.16 | 100% | +0% |
| Pharmaceutical & specialty | 55.37 | 92% | +0% |
| GMPD | 3.20 | 5% | +3% |
| All other | 1.61 | 3% | +37% |
| Other and unallocated | −0.02 | 0% | |
| Cost of revenue | −57.96 | 96% | |
| Gross profit | 2.20 | 4% margin | +1pp |
| SG&A | −1.48 | 2% | +0pp |
| Other | −0.29 | 1% | +0pp |
| Operating profit | 0.43 | 1% margin | +0pp |
| Tax | −0.19 | ||
| Net profit | 0.24 | 0% margin | +0pp |
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 54.88 | 100% | +0% |
| Pharmaceutical & specialty | 50.43 | 92% | +0% |
| GMPD | 3.16 | 6% | +2% |
| All other | 1.30 | 2% | +13% |
| Cost of revenue | −52.76 | 96% | |
| Gross profit | 2.12 | 4% margin | +0pp |
| SG&A | −1.32 | 3% | +0pp |
| Other | −0.08 | 0% | +0pp |
| Operating profit | 0.73 | 1% margin | +1pp |
| Interest & other costs | −0.07 | ||
| Tax | −0.16 | ||
| Net profit | 0.51 | 1% margin | +0pp |
Financial health
The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.
The balance sheet, capital flow, debt schedule and capital structure open with a free account.
Quarter by quarter
Every set of results we hold, newest first. Open one on its own page. The arrow beside a quarter shows it in the diagram above.
| Quarter | Period | Reported | Revenue | Year over year | Operating margin | Net profit | Net margin |
|---|---|---|---|---|---|---|---|
| Q2 FY26 Oct 1 – Dec 31, 2025 reported Feb 5, 2026 Operating margin 1% Net profit $0.47B | Oct 1 – Dec 31, 2025 | Feb 5, 2026 | $65.6B | +19% | 1% | $0.47B | 1% |
| Q1 FY26 Jul 1 – Sep 30, 2025 reported Oct 30, 2025 Operating margin 1% Net profit $0.45B | Jul 1 – Sep 30, 2025 | Oct 30, 2025 | $64.0B | +22% | 1% | $0.45B | 1% |
| Q4 FY25 Apr 1 – Jun 30, 2025 reported Aug 12, 2025 Operating margin 1% Net profit $0.24B | Apr 1 – Jun 30, 2025 | Aug 12, 2025 | $60.2B | +0% | 1% | $0.24B | 0% |
| Q3 FY25 Jan 1 – Mar 31, 2025 reported May 1, 2025 Operating margin 1% Net profit $0.51B | Jan 1 – Mar 31, 2025 | May 1, 2025 | $54.9B | +0% | 1% | $0.51B | 1% |
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest